1. Home
  2. WLFC vs COLL Comparison

WLFC vs COLL Comparison

Compare WLFC & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Willis Lease Finance Corporation

WLFC

Willis Lease Finance Corporation

HOLD

Current Price

$120.20

Market Cap

1.0B

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$46.52

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLFC
COLL
Founded
1985
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
WLFC
COLL
Price
$120.20
$46.52
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$45.40
AVG Volume (30 Days)
57.4K
624.2K
Earning Date
11-04-2025
11-06-2025
Dividend Yield
1.30%
N/A
EPS Growth
17.99
N/A
EPS
16.70
1.63
Revenue
$674,381,000.00
$757,067,000.00
Revenue This Year
$16.17
$21.41
Revenue Next Year
$4.88
$3.28
P/E Ratio
$7.35
$28.72
Revenue Growth
29.58
26.34
52 Week Low
$114.01
$23.23
52 Week High
$229.67
$48.18

Technical Indicators

Market Signals
Indicator
WLFC
COLL
Relative Strength Index (RSI) 45.62 73.19
Support Level $114.01 $45.33
Resistance Level $135.00 $46.48
Average True Range (ATR) 5.23 1.63
MACD 0.20 -0.01
Stochastic Oscillator 37.38 73.95

Price Performance

Historical Comparison
WLFC
COLL

About WLFC Willis Lease Finance Corporation

Willis Lease Finance Corp, with its subsidiaries, is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments, which include Leasing and Related Operations and Spare Parts Sales. A majority of its revenue is generated from the Leasing and Related Operations segment, which involves acquiring and leasing, under operating leases, commercial aircraft, aircraft engines, and other aircraft equipment and the selective purchase and resale of commercial aircraft engines, aircraft equipment, and other related businesses. Geographically, the company derives maximum revenue from the United States, followed by Europe, Asia-Pacific (excluding India), India, South America, Canada, Central America, and the Middle East.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: